Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
133,765,508
-
Total 13F shares
-
10,205,400
-
Share change
-
-1,854,176
-
Total reported value
-
$47,664,000
-
Price per share
-
$4.67
-
Number of holders
-
25
-
Value change
-
-$8,840,870
-
Number of buys
-
12
-
Number of sells
-
15
Institutional Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q3 2021
As of 30 Sep 2021,
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) was held by
25 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,205,400 shares.
The largest 10 holders included
RENAISSANCE TECHNOLOGIES LLC, Oasis Management Co Ltd., Man Group plc, BlueCrest Capital Management Ltd, Quinn Opportunity Partners LLC, BARCLAYS PLC, ARROWSTREET CAPITAL, LIMITED PARTNERSHIP, Qube Research & Technologies Ltd, NATIXIS ADVISORS, L.P., and Verition Fund Management LLC.
This page lists
25
institutional shareholders reporting positions in this security
for the Q3 2021 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.